According to a new report from Intel Market Research, the Europe prostate cancer devices market was valued at USD 567.8 million in 2024 and is projected to grow from USD 605.0 million in 2025 to USD 845.6 million by 2030, exhibiting a robust CAGR of 6.9% during the forecast period (2025–2030). This growth is driven by an aging male population with a higher risk profile, continuous...